Cannabinoids – CBDa


A study from September 2008 examined CBDA’s potential anti-inflammatory properties through its selective inhibition of the COX-2 enzyme. A September 2012 study researched CBDA as a possible anti-cancer agent. The antiemetic effects of CBDA was the subject of a February 2013 study. A January 2017 study suggested CBDA may have application in the treatment of aggressive breast cancer.


Latest posts